{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:08:12Z","timestamp":1789758492744,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KU1214B"],"award-info":[{"award-number":["01KU1214B"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jhep.2014.05.019","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T19:45:10Z","timestamp":1400183110000},"page":"883-890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice"],"prefix":"10.1016","volume":"61","author":[{"given":"Daniela C.","family":"Kroy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Ramadori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Hatting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Bergheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Gassler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark V.","family":"Boekschoten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad L.","family":"Streetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Trautwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2014.05.019_b0005","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","article-title":"Liver fibrosis \u2013 from bench to bedside","volume":"38","author":"Friedman","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.05.019_b0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3748\/wjg.14.185","article-title":"Non-alcoholic fatty liver disease and the metabolic syndrome: an update","volume":"14","author":"Rector","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2014.05.019_b0015","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.05.019_b0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2001-12926","article-title":"Clinical features and natural history of nonalcoholic steatosis syndromes","volume":"21","author":"Falck-Ytter","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2014.05.019_b0025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.05.019_b0030","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","article-title":"A position statement on NAFLD\/NASH based on the EASL 2009 special conference","volume":"53","author":"Ratziu","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.05.019_b0035","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2009.03.019","article-title":"Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis","volume":"51","author":"Argo","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.05.019_b0040","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.cld.2009.07.005","article-title":"Epidemiology and natural history of non-alcoholic steatohepatitis","volume":"13","author":"Argo","year":"2009","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2014.05.019_b0045","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.05.019_b0050","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2014.05.019_b0055","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.23527","article-title":"The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis","volume":"51","author":"Ascha","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.05.019_b0060","doi-asserted-by":"crossref","first-page":"14581","DOI":"10.1074\/jbc.M707733200","article-title":"Hepatocyte-specific c-Met deletion disrupts redox homeostasis and sensitizes to Fas-mediated apoptosis","volume":"283","author":"Gomez-Quiroz","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.05.019_b0065","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/gut.2003.024935","article-title":"Cytokines and the pathogenesis of non-alcoholic steatohepatitis","volume":"54","author":"Diehl","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2014.05.019_b0070","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/373699a0","article-title":"Scatter factor\/hepatocyte growth factor is essential for liver development","volume":"373","author":"Schmidt","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2014.05.019_b0075","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/373702a0","article-title":"Placental defect and embryonic lethality in mice lacking hepatocyte growth factor\/scatter factor","volume":"373","author":"Uehara","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2014.05.019_b0080","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1097-2765(02)00439-2","article-title":"A mechanism of cell survival: sequestration of Fas by the HGF receptor Met","volume":"9","author":"Wang","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.jhep.2014.05.019_b0085","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/nm1625","article-title":"Lack of Fas antagonism by Met in human fatty liver disease","volume":"13","author":"Zou","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2014.05.019_b0090","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/hep.21604","article-title":"Met signals hepatocyte survival by preventing Fas-triggered FLIP degradation in a PI3k-Akt-dependent manner","volume":"45","author":"Moumen","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.05.019_b0095","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0092-8674(94)90318-2","article-title":"A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor\/scatter factor receptor family","volume":"77","author":"Ponzetto","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2014.05.019_b0100","doi-asserted-by":"crossref","first-page":"10608","DOI":"10.1073\/pnas.0403412101","article-title":"Met provides essential signals for liver regeneration","volume":"101","author":"Borowiak","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.05.019_b0105","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1194\/jlr.M800042-JLR200","article-title":"Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet","volume":"49","author":"Rinella","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2014.05.019_b0110","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2009.01.068","article-title":"C-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice","volume":"137","author":"Giebeler","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.05.019_b0115","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1440-1746.2009.05785.x","article-title":"Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression","volume":"24","author":"Farrell","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2014.05.019_b0120","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/sj.onc.1205297","article-title":"Hepatocyte growth factor\/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway","volume":"21","author":"Paumelle","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2014.05.019_b0125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1073\/pnas.98.1.247","article-title":"Anti-apoptotic signaling by hepatocyte growth factor\/Met via the phosphatidylinositol 3-kinase\/Akt and mitogen-activated protein kinase pathways","volume":"98","author":"Xiao","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.05.019_b0130","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/hep.510250321","article-title":"Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma","volume":"25","author":"Ueki","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.05.019_b0135","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/hep.24450","article-title":"C-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma","volume":"54","author":"You","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.05.019_b0140","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1158\/1078-0432.CCR-12-2791","article-title":"Targeting the HGF\/c-MET pathway in hepatocellular carcinoma","volume":"19","author":"Goyal","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2014.05.019_b0145","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1158\/1535-7163.MCT-05-0106","article-title":"Knockdown of c-Met by adenovirus-delivered small interfering RNA inhibits hepatocellular carcinoma growth in vitro and in vivo","volume":"4","author":"Zhang","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jhep.2014.05.019_b0150","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jss.2009.04.030","article-title":"Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference","volume":"162","author":"Xie","year":"2010","journal-title":"J Surg Res"},{"key":"10.1016\/j.jhep.2014.05.019_b0155","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1083\/jcb.153.5.1023","article-title":"Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice","volume":"153","author":"Wang","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jhep.2014.05.019_b0160","doi-asserted-by":"crossref","first-page":"14771","DOI":"10.1073\/pnas.0706578104","article-title":"Distinct pathways of genomic progression to benign and malignant tumors of the liver","volume":"104","author":"Tward","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.05.019_b0165","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/sj.onc.1205199","article-title":"Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation","volume":"21","author":"Amicone","year":"2002","journal-title":"Oncogene"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814003602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814003602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T21:52:03Z","timestamp":1780955523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827814003602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0168827814003602"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2014.05.019","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2014.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}